Related Experiment Video
Updated: Oct 17, 2025
12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
14.2K
Recent advances in combating Nipah virus
Kendra Johnson1, Michelle Vu1, Alexander N Freiberg2
1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Faculty Reviews
|October 11, 2021
Summary
Nipah virus (NiV) is a dangerous bat-borne virus causing severe human illness and economic losses. This review discusses progress in developing crucial therapeutic treatments for NiV infection.
Area of Science:
- Virology
- Zoonotic Diseases
- Public Health
Background:
- Nipah virus (NiV) is a highly pathogenic bat-borne paramyxovirus responsible for severe respiratory disease and encephalitis in humans.
- Human-to-human transmission of NiV has been confirmed in multiple outbreaks, posing a significant public health threat.
- NiV also infects various mammals, including agricultural species, leading to substantial economic consequences.
Purpose of the Study:
- To review the current progress in developing therapeutic measures against Nipah virus infection.
- To highlight the urgent need for effective treatments due to NiV's severity and pandemic potential.
Main Methods:
- Literature review of published research on Nipah virus.
- Analysis of therapeutic strategies and drug development pipelines for NiV.
Main Results:
- Nipah virus remains a global health priority due to its high mortality rate and lack of approved treatments.
- Ongoing research focuses on antiviral therapies, vaccines, and supportive care strategies.
Conclusions:
- Development of effective therapeutics for Nipah virus is critical to prevent future pandemics.
- Continued research and international collaboration are essential for NiV countermeasures.
